Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention.
Eun-Seok ShinAe-Young HerBitna KimJoo-Yong HahnYoung Bin SongJoo-Myung LeeTaek Kyu ParkJeong Hoon YangJin Ho ChoiSeung-Hyuk ChoiSang Hoon LeeHyeon Cheol Gwonnull nullPublished in: Journal of Korean medical science (2023)
ClinicalTrials.gov Identifier: NCT02079194.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- patients undergoing
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- combination therapy
- coronary artery bypass
- atrial fibrillation
- open label
- randomized controlled trial
- clinical trial
- type diabetes
- left ventricular
- metabolic syndrome
- insulin resistance
- study protocol